Abstract

Providing Positive Outcomes through Compounding for Animal Cancer Patients

Author(s): Davidson Gigi S

Issue: Jul/Aug 2000 - Compounding for Hospice and Cancer Patients

Page(s): 264-272

Download in electronic PDF format for $75
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 1
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 2
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 3
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 4
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 5
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 6
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 7
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 8
  • Providing Positive Outcomes through Compounding for Animal Cancer Patients Page 9

Abstract

The role of the compounding pharmacist is critical during the treatment of animals with cancer. In this article, the author discusses methods of therapy, considerations for extrapolation of therapies, chemoresponsive tumors (lymphoma, mast cell tumor, osteosarcoma, bladder cancer, postvaccinal sarcomas, equine tumors, sarcoids, squamous cell carcinoma and melanoma), specific intralesional and topical chemotherapy and immunotherapy, adverse sequelae to cancer treatment in animal patients, therapeutic options for pain in the cancer patient and frontiers of veterinary cancer therapy. She also provides tables with the following information: a chart showing conversion of body weight in kilograms to body surface area in meters squared for dogs, a chart showing conversion of body weight in kilograms to body surface area in meters squared for cats, compounded cancer treatment options for oral administration, considerations for extrapolation of human therapies to animal patients, a treatment protocol for canine lymphoma, a feline lymphoma treatment protocol, canine mast cell tumor treatment options, a canine osteosarcoma treatment protocol, a feline vaccine-associated sarcoma treatment protocol, equine sarcoid treatment options, equine squamous cell carcinoma treatment options, equine melanoma treatment options, compounded intralesional and topical chemotherapeutic agents, treatment options for adverse sequelae to cancer treatment and therapeutic options for pain management in the veterinary cancer patient.

Related Keywords

  • animal patients
  • animals
  • antineoplastic
  • bladder cancer
  • cancer
  • cat
  • chemotherapy
  • cytotoxic
  • dog
  • equine tumors
  • horse
  • immunotherapy
  • lyphoma
  • mast cell tumor
  • melanoma
  • oncolgists
  • osteosarcoma
  • pets
  • postvaccinal sarcomas
  • sarcoids
  • squamous cell carcinoma
  • veterinary

Related Categories

  • CANCER AND AIDS
  • VETERINARY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2000
Pg. 264-272
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Author(s): Davidson Gigi S
Jan/Feb 2009
Pg. 42-49
Compounding for Cancer in Companion Animals
Author(s): Mixon William, Northrup Nicole, Vail Jane
May/Jun 2005
Pg. 195-198
Compounding Antiangiogenic Cancer Therapy for Animals
Author(s): Davidson Gigi S
Jul/Aug 2000
Pg. 257-260
Surviving Cancer - How the Compounding Pharmacist Can Help
Author(s): Maddox Suzan
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 62
Calculations: Compounding for Cancer Patients
Author(s): Stockton Shelly J
Sep/Oct 2019
Pg. 358-364
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Author(s): Pope George, Daleo Charles, Batson SL
May/Jun 2013
Pg. 262-263
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial
Author(s): Williams LaVonn A
Jul/Aug 2012
Pg. 276-286
Compounding Prokinetic Medications for Companion Animals
Author(s): Gaskins Jessica
Jan/Feb 2008
Pg. 16-27
Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients
Author(s): Williams LaVonn A
Jul/Aug 2002
Pg. 250-254
The Hormonal Link to Breast Cancer: The Estrogen Matrix
Author(s): Zava David T
Jul/Aug 1997
Pg. 242-243
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
May/Jun 1997
Pg. 175
Antiemetic Injection for Cancer Chemotherapy
Author(s): Allen Loyd V Jr
Jul/Aug 1997
Pg. 258
Hair Moisturizer/Conditioner for Horses and Other Animals
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 449
Calculations: Compounding for Large and Small Animals
Author(s): Stockton Shelly J
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
May/Jun 2005
Pg. 178-182
View Sample
Update on Transdermals for Animal Patients
Author(s): Davidson Gigi S
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
Nov/Dec 2025
Pg. 477-486
Impact Of Caloric Intake In Cancer Cachexic Patients On Nandrolone - A Prospective Observational Study
Author(s): James Apollo, Mary Priscilla, Vinayagam Pavithra, O Ashiq, Maheswari
May/Jun 2005
Pg. 185-192
Compounding for Behavior Problems in Animals
Author(s): Vail Jane, Davidson Gigi S